This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Pharmaceutical Manufacturing Research Services, Inc.. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Innovations by Nicholas R Myslinski
Introduction
Nicholas R Myslinski is a notable inventor based in Bensalem, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in developing abuse deterrent dosage forms. With a total of 7 patents to his name, his work focuses on enhancing the safety and efficacy of medications.
Latest Patents
One of his latest patents is for an "Extended release abuse deterrent liquid fill dosage form." This invention relates to an oral dosage form that includes a controlled release agent and at least one active pharmaceutical ingredient susceptible to abuse. The formulation is designed to be stable at high temperatures and provides deterrence against abuse through various methods of administration. Another significant patent is the "Extruded extended release abuse deterrent pill." This oral pill contains a drug homogenously spread throughout a matrix and can be prepared using a hot melt extrusion process. It meets regulatory guidelines for extended release formulations and is designed to deter abuse through its physical properties.
Career Highlights
Nicholas R Myslinski is associated with Pharmaceutical Manufacturing Research Services, Inc., where he continues to innovate in the pharmaceutical industry. His work has been instrumental in developing safer medication options for patients.
Collaborations
He has collaborated with notable coworkers, including Edwin R Thompson and Eric R Thompson, contributing to the advancement of pharmaceutical technologies.
Conclusion
Nicholas R Myslinski's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving medication safety. His work continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile